![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24798-24806, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
,
,
,
,
,
,
,
,
, and
From the
Molecular Genetics Group and ¶ Human
Genetics Group, John Curtin School of Medical Research, Australian
National University, Canberra, Australian Capital Territory 2601, Australia, ** Australian Genomic Information Centre, University of
Sydney, New South Wales 2006, Australia, and

Pfizer Global Research and Development,
Groton, Connecticut 06340
Received for publication, March 2, 2000, and in revised form, April 10, 2000
| |
ABSTRACT |
|---|
|
|
|---|
A new class of glutathione transferases has been
discovered by analysis of the expressed sequence tag data base and
sequence alignment. Glutathione S-transferases (GSTs) of
the new class, named Omega, exist in several mammalian species and
Caenorhabditis elegans. In humans, GSTO 1-1 is expressed in
most tissues and exhibits glutathione-dependent thiol
transferase and dehydroascorbate reductase activities characteristic of
the glutaredoxins. The structure of GSTO 1-1 has been determined at
2.0-Å resolution and has a characteristic GST fold (Protein Data Bank
entry code 1eem). The Omega class GSTs exhibit an unusual N-terminal
extension that abuts the C terminus to form a novel structural unit.
Unlike other mammalian GSTs, GSTO 1-1 appears to have an active site cysteine that can form a disulfide bond with glutathione.
The glutathione transferases
(GSTs)1 are a family of phase
II enzymes that utilize glutathione in reactions contributing to the
biotransformation and disposition of a wide range of exogenous and
endogenous compounds. These include chemical carcinogens, therapeutic
drugs, and products of oxidative stress (1). GST expression levels and
the factors modulating them can have significant biological and
clinical implications. Overexpression of some GSTs is implicated in
resistance to several anti-cancer drugs (1). In contrast, genetically
determined GST deficiencies are risk factors for cataract and several
forms of cancer (1, 2), and homozygosity for the GSTM 1 null
allele is a positive prognostic indicator for successful chemotherapy
and long term survival in childhood acute lymphoblastic leukemia (3).
Genetic polymorphisms influencing the substrate specificity of GSTP
1-1 (4) are risk factors for Parkinson's disease in subjects exposed
to pesticides (5)
Based on their sequences, the mammalian cytosolic GSTs form six
evolutionarily distinct classes termed Alpha, Mu, Pi, Sigma, Theta, and
Zeta (1, 6). There may also be additional classes in plants, insects,
and other species (6). Although some members of the different GST
classes exhibit overlapping substrate specificities, others are highly
specific. Despite the diversity of substrates metabolized by this large
family, many GSTs were originally identified through their activity
with the xenobiotic 1-chloro-2,4-dinitrobenzene and their ability to
bind to glutathione affinity matrices. To identify new members of the
glutathione transferase gene family on the basis of sequence similarity
rather than substrate specificity, we have searched a data base
containing sequences of more than 106 human expressed
sequence tags.
This analysis has led to identification of the class Omega glutathione
transferases, a group of GSTs with novel structural and functional
characteristics. We have identified a human cDNA, expressed and
characterized the recombinant protein, and determined its crystal
structure to 2.0-Å resolution. Recombinant human Omega class GST (GSTO
1-1) exhibits a glutathione-dependent thiol transferase activity and catalyzes glutathione-dependent reduction of
dehydroascorbate. These activities are not associated with other human
GSTs but are characteristic of the glutaredoxins (7). The Omega class GSTs have a unique N-terminal extension, and the crystal structure reveals an active site cysteine residue distinct from the tyrosine and
serine residues characteristic of other eukaryotic GSTs (8-10).
EST Identification and DNA Sequencing--
The human EST
data base was searched using the tBLASTn version of the BLAST program
(11) with human Theta and Zeta class amino acid sequences as query
sequences. An EST (GenBankTM accession number W38456) encoding an
unknown protein with low similarity to both Theta and Zeta class
GSTs was identified, and the cDNA clone was obtained from the
I.M.A.G.E. consortium. The complete cDNA sequence was
obtained on each strand by subcloning restriction fragments and by the
use of a Thermo sequenase kit (Amersham Pharmacia Biotech). The
cDNA sequence has been submitted to GenBankTM as accession number
AF212303.
Alignment and Phylogenetic Analysis of Representative GST and
GST-like Amino Acid Sequences--
Although a large number of GSTs and
related protein sequences are available, to simplify computations and
to promote legibility, representative GST and GST-like amino acid
sequences were selected from previously described GST classes and
related proteins. The sequences were obtained from GenBankTM and
aligned using CLUSTAL W (12) and GDE (13). The revised alignment, which
agrees with predictions based on molecular modeling and crystal
structure, is available from Dr. P. Board at the John Curtin School of
Medical Research web site.
A phylogenetic tree was obtained by maximum likelihood analysis of all
the sites in the above-mentioned alignment. The data was analyzed using
the JTT-F substitution model (14), and local bootstrap probabilities
were estimated for the internal branches using the PROTML program
(15).
The phylogenetic analysis involved two examinations of the sequence
alignment with different input order of the sequences. Each analysis
involved two steps: stepwise addition and nearest neighbor
interchanges. The most likely tree was compared with the remaining
trees using the test of Kishino and Hasegawa (16).
Recombinant Protein Expression--
Recombinant GSTO 1-1 was
expressed in Escherichia coli and purified by two separate
methods using either the pGEX2T vector (Amersham Pharmacia Biotech,
Piscataway, NJ) and glutathione affinity chromatography or the
pQE30 vector (Qiagen) and nickel agarose affinity
chromatography. Specifically, the GSTO1 cDNA was amplified by polymerase chain reaction (sense primer
5'-AGGATCCACGATGTCCGGGGAGTCAG-3', antisense primer
5'-CGAATTCAGAGCCCATAGTCACAG-3') and cloned between the
BamHI and EcoRI sites of the bacterial expression
vector pGEX2T (Amersham Pharmacia Biotech), and transformed into BL21
[DE3] cells (Novagen, Milwaukee, WI). Briefly, a seed culture of the transformed cells was grown to A600 of 0.4-0.6,
scaled up, and grown again to the same density, induced with IPTG (50 µM), and grown for a further 2 h at 37 °C. The
GST fusion protein product was purified from the soluble fraction of a
cell lysate and cleaved with thrombin. GSTO 1-1 was isolated by further
chromatography using anion exchange.2
Recombinant GSTO 1-1 was also expressed with an N-terminal 6×His tag
from the plasmid pQE30 and purified on nickel agarose largely as
described for the preparation of recombinant mouse GSTT 1-1 (17). The
enzyme was eluted in 500 mM imidazole, 50 mM
sodium phosphate, 300 mM NaCl, pH 8.0, and was essentially pure as judged by SDS-PAGE. The purified protein was dialyzed against
20 mM Tris-Cl, 60 mM NaCl, 5 mM
dithiothreitol, pH 8.0, before storage at Expression and Purification of Selenomethionine
(SeMet)-substituted GSTO 1-1--
For crystallography by the
multiwavelength anomalous dispersion method, GSTO 1-1 was expressed as
a SeMet-substituted protein. pGEX-2T with the GSTO 1-1 insert was
transformed into the methionine auxotroph E. coli B834
(Novagen), and the resulting cells were grown in the presence of 100 mg/liter D,L-selenomethionine (Bachem) essentially as described previously (18).2
Crystal Growth--
Purified GSTO 1-1 was exchanged into fresh
0.025 M Tris-HCl, 0.06 M NaCl, 5 mM
dithiothreitol, pH 7.5, and brought to 20-25 mg/ml in Centricon units
(Millipore, Bedford, MA). When the intent was to crystallize the
covalent glutathione adduct of GSTO 1-1, dithiothreitol was used at 1 mM, and GSH:GSSG (5:1) was added to 2 mM.
Screening by hanging drop/vapor diffusion using Crystal Screen I
(Hampton Research, Laguna Hills, CA) identified a condition (#47)
requiring minimal optimization. Both glutathione-complexed and
glutathione-free crystals grew in drops containing 8-12 mg/ml protein
with 50 mM sodium acetate, pH 4.6, and 1.0-1.2
M (NH4)2SO4.
Quaternary Structure of GSTO 1-1--
Size exclusion
chromatography was conducted on a Amersham Pharmacia Biotech fast
protein liquid chromatography system using a Superdex 75 HR 10/30
column equilibrated with phosphate-buffered saline and run at a flow
rate of 0.8 ml/min. Standards (Sigma) included bovine serum albumin (66 kDa), bovine carbonic anhydrase (29 kDa), horse cytochrome c
(12.4 kDa), and bovine aprotinin (6.5 kDa).
Sedimentation equilibrium studies were performed using a Beckman XLA
analytical ultracentrifuge. Sample concentrations of 0.11, 0.17, and
0.34 mg/ml in charcoal epon cells were centrifuged at rotor speeds of
18,000, 25,000, and 31,000. Samples were referenced to the dialysis
buffer (phosphate-buffered saline, 5 mM dithiothreitol). Data were analyzed using the program NONLIN (University of Connecticut, Storrs, CT).
Enzyme Assays--
Enzymatic activity with a range of substrates
(Table I) was determined as
described (6, 17, 19). Thiol transferase activity was measured with
hydroxyethyl disulfide as a substrate (20), and
glutathione-dependent dehydroascorbate reductase activity was determined spectrophotometrically with dehydroascorbate prepared immediately before use (21). For the thiol transferase and
dehydroascorbate reductase assays, the purified enzyme was dialyzed
against 20 mM Tris-HCl, 60 mM NaCl, pH 8.0, to
remove dithiothreitol.
Northern and Western Blotting--
Northern blots containing
mRNA from multiple human tissues obtained from
CLONTECH (Palo Alto, CA) were hybridized with
32P-labeled GSTO 1-1 cDNA in ExpressHyb
(CLONTECH, Palo Alto, CA) at 68 °C and washed
according to the manufacturer's instructions. The filters were
subsequently hybridized with a labeled Data Collection--
Multiwavelength anomalous dispersion data
were collected from crystals of SeMet-substituted apo-GSTO 1-1 on Beam
Line X12-C of the National Synchrotron Light Source at the Brookhaven
National Laboratory, Brookhaven, New York. Before data collection at
100 K, crystals were transferred to a cryoprotectant solution of 2.0 M Li2SO4 and 5% glycerol. The
Se-absorption edge was determined by a fluorescence scan, and three
wavelengths were selected for data collection corresponding to the peak
(maximum f ', Structure Determination--
Four of the seven expected selenium
sites were found in anomalous difference Patterson maps calculated at
the peak anomalous wavelength using the program PATSOL (25), and
initial phases were calculated with SHARP (26). Examination of
log-likelihood gradient maps revealed two more selenium sites. The last
remaining selenium site corresponding to methionine near the N terminus (the fourth amino acid residue of the recombinant protein) was disordered and was not placed. Phase calculation in SHARP using the six
located sites gave phases with an excellent overall figure of merit
(Table II). 2.1 Å resolution maps calculated after density modification by histogram matching and solvent flipping in SOLOMON (27)
were used for model building (Fig.
1).
Model Building and Refinement--
The initial model was built
using the program O (28). The high quality of the initial experimental
electron density map and known selenium sites allowed unambiguous
tracing for all of the protein backbone and side chains except for the
first seven amino acids. The first three (Gly-Ser-Thr) were a legacy of
the recombinant construct. The protein model was refined against 2.0-Å data collected from native (non SeMet) crystals of the GSTO 1-1 complex
with GSH. Refinement was carried out using conjugate-gradient least
squares and simulated-annealing protocols in X-PLOR 3.851 (29) and
monitored with the Rfree value using a 5%
randomly selected test set. A model for GSH covalently bound to Cys-32 as well as chemically reasonable water molecules and sulfate ions was
built into DNA and Protein Sequence--
BLAST searches of the human EST data
base with residues 1-100 of human GSTZ1 (6) revealed clones with
around 40% sequence identity with the residues between positions 19 and 77 of GSTZ1. Preliminary alignments suggested these were distinct
from previously described human GSTs, and a representative EST clone
(GenBankTM accession number W38456) was selected for
further characterization. Subsequent studies revealed that
this cDNA encoded a protein belonging to a distinct new class
within the GST family. This class has been named Omega in accordance
with established guidelines (31).
Sequencing of both strands of the cDNA contained in the EST clone
W38456, which we termed pGSTO 1, revealed 26 base pairs of 5'
non-coding sequence, 723 base pairs of coding sequence, and 51 base
pairs of 3' non-coding sequence (Fig. 2).
The cDNA encodes a peptide of 241 residues with a predicted
molecular mass of 27,566 Da. A similar cDNA sequence encoding the
same peptide has been submitted to GenBankTM by others with accession
number U90313. Alignment of the deduced amino acid sequence with
representative sequences from previously described GST classes and
GST-like proteins2 highlights the similarities and significant
differences between GSTO 1-1 and the previously defined classes.
Although we first identified GSTO 1-1 as a human EST, searches of
additional data bases have identified highly similar sequences in the
mouse (U80819), rat (AB008807), and a nematode (Caenorhabditis
elegans) (P34345). These have 72, 76, and 34% sequence identity
respectively. A pig EST (F14520) also shows sufficient similarity over
its incomplete sequence to be placed in the Omega class.
The sequence alignment was used to generate a phylogenetic tree using
the maximum-likelihood approach. The tree in Fig.
3 is the most likely tree; another five
locally optimal trees were identified, none differing significantly
from the most likely tree. The tree in Fig. 3 clearly groups human
Omega with the homologous sequences from the mouse, rat, and nematode
in a distinct cluster, supporting the designation of this group as the
Omega class. The alignment and tree also show that the Zeta class is
the most similar of the previously defined classes and that the well
characterized GST classes are all supported by local bootstrap
probabilities ranging from 90 to 100%. Several sequences not yet
clearly characterized as GSTs (i.e. soybean heat-shock
protein, yeast membrane protein, and E. coli stringent
starvation protein) were included in the alignment because they appear
to be members of the GST structural family. The phylogenetic
relationships of these sequences are uncertain, but there is an
indication that the potato GST and soybean heat-shock protein are part
of the Omega class.
A notable feature of the human, mouse, pig, and nematode Omega GSTs is
a 19-20-residue N-terminal extension not found in any previously
described GST. This was not noted in the homologous rat sequence
reported as a glutathione-dependent dehydroascorbate reductase (32), but translation with a reading frame adjustment of the
rat sequence upstream of the reported translation-initiating ATG codon
reveals an N-terminal sequence similar to that in the other species.
Additional rat cDNAs need to be sequenced to determine if there is
a species difference or if there is a cloning artifact in the clone
reported by Ishikawa et al. (32).
GSTO 1 Expression--
Northern blots of RNA from a range of human
tissues showed a single hybridizing species of approximately 0.8 kilobases (Fig. 4). The level of
hybridization indicates that GSTO 1 mRNA is expressed in all
tissues tested, with the greatest expression in liver, skeletal muscle,
and heart and relatively low levels in brain, placenta, and lung. The
level of expression in skeletal muscle and heart is difficult to judge
accurately because the loading control hybridization with a Characterization of Recombinant GSTO 1-1--
A Western blot of
cytosolic extracts from human liver and Jurkat cells revealed a single
cross-reacting protein with an apparent mass of 31 kDa (not shown),
co-migrating with purified recombinant GSTO 1. As the deduced amino
acid sequence predicts a mass of 27.5 kDa, GSTO 1 migrates anomalously
in reducing SDS-PAGE. Size exclusion chromatography of recombinant GSTO
1 on a calibrated Superdex 75 HR 10/30 column estimated its mass as 56 kDa, indicating that GSTO 1 forms a dimer (GSTO 1-1) under native
conditions. Sedimentation equilibrium experiments were conducted at
protein concentrations of 0.11, 0.17, and 0.34 mg/ml. For the two
higher concentrations, NONLIN analysis yielded good fits to molecular masses of 54,545 Da (0.34 mg/ml) and 54,145 Da (0.17 mg/ml), each indicating a dimer. The data collected at 0.11 mg/ml displayed evidence
of some non-ideality and fit better to a model taking account of some
non-equilibrium behavior (90% dimer and 10% incompetent monomer).
More extensive studies would be needed to confirm this observation and
extend it into a lower concentration range.
To test recombinant GSTO 1-1 for GST-like activities, assays were
performed with compounds that are substrates for GSTs of other classes.
Also, as the homologous rat sequence was reported to encode a
glutathione-dependent dehydroascorbate reductase (32), that
activity and glutathione-dependent thiol transferase
activity were determined. GSTO 1-1 has little activity with most GST
substrates (Table I). There was low but detectable activity with
1-chloro-2,4-dinitrobenzene, which is generally a good substrate for
members of the Alpha, Mu, and Pi classes. Similarly, there was low but
measurable activity with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole
(NBD-Cl) trans-octenal and trans-nonenal,
substrates utilized preferentially by Alpha class GSTs (22).
Glutathione-dependent dehydroascorbate reductase activity
was detected in preparations of recombinant human GSTO 1-1. This has
been reported in a number of tissues from several species (33) and, in
most cases, attributed to glutaredoxin (also termed thiol transferase).
Consequently, the thiol transferase activity of the recombinant enzyme
was determined and found to be the highest of all the activities
investigated (Table I) Similar results were obtained with GSTO 1-1 prepared from a GST fusion or with an N-terminal His tag. Thus the
Omega class GSTs have activities similar to those of the glutaredoxins.
Similarities in the protein fold of the glutaredoxins and the
N-terminal domain of the cytosolic GSTs have been noted (34), and low
thiol transferase activity (74.3 nmol/mg/min) has been attributed to a
Mu class GST from bovine lens (35). In other unpublished studies we
examined the thiol transferase activity of a range of GSTs from the
Alpha, Mu, Pi, Theta, and Zeta classes (GSTA 1-1, GST 2-2, GSTA 4-4, GSTM 1-1, GSTM 2-2, GSTM 3-3, GSTM 4-4, GSTP 1-1, GSTT 2-2, GSTT 1-1, GST Z 1-1). With the exception of GSTM2-2, which had low activity, all
were essentially inactive. It is therefore clear that the
glutaredoxin-like activities of GSTO 1-1 are not a common feature of
other cytosolic GSTs despite similarities in their structure.
Crystal Structure of GSTO 1-1--
The structure of a covalent
complex between GSTO 1-1 and GSH was determined to 2.0-Å resolution by
multiwavelength anomalous dispersion. Multiwavelength anomalous
dispersion data to 2.1 Å resolution were collected from crystals of
SeMet-substituted apo-GSTO 1-1 (Table II). The crystals are
trigonal, belong to space group P3121, and have a single
polypeptide in the asymmetric unit. Two monomers related by the
crystallographic 2-fold axis form a dimer, as is characteristic of GSTs
(Fig. 5A).
GSTO 1-1 has modest sequence identity with the GSTs for which crystal
structures are known but clearly adopts the canonical GST fold (Fig.
5B). There are two domains, an N-terminal thioredoxin-like domain, and a C-terminal domain that is all
Of the seven G-site and the Recognition of GSH--
Two features of GSH binding
distinguish GSTO 1-1 from typical GSTs. The first is that Cys-32 makes
a mixed disulfide with GSH, as seen also in the bacterial enzyme PmGST
B1-1 (36). As noted in that case, the presence of this disulfide
prompts caution in considering possible catalytic functions of GSTO
1-1. It is unclear what catalytic residues would stabilize the thiolate
form of glutathione for the standard GST function of transferring it to
an electrophile. In the human Mu class enzyme GSTM2-2 it has been
suggested that movement of a positvely charged Arg residue into the
catalytic pocket promotes the ionization of the sulfhydryl group of GSH
(37). However, examination of the GSTO 1-1 structure has not identified
any atoms within 5 Å of the Cys-32 thiol that could be involved in
stabilizing a thiolate ion.
Cys-32 is located at the N terminus of
The second novel feature is the absence of interactions between GSH
bound to one polypeptide and groups of the other polypeptide. In the
other known GST structures, except for the Theta-like GSTs from plant
(Arabidopsis thaliana (39)) and insect (Lucilia
cuprina (40)) species, there is a salt bridge between the
N-terminal nitrogen of GSH and an acidic residue on helix
In all other respects, GSH binding is analogous to what has been
observed in other GSTs. All the interactions of GSH with the protein
are made with the N-terminal domain, and residues that contribute to
binding GSH are either conserved or conservatively replaced in all the
GSTs (Fig. 9). Glu-85, which forms a
H-bond with the amino group of GSH, has strained backbone
stereochemistry and is in the generously allowed region of the
Ramachandran plot. The equivalent residue in other GST structures also
adopts a strained conformation (10).
The H-site--
Many GSTs catalyze conjugation of the thiol group
of GSH to an electrophile, often a component of a toxic xenobiotic with some hydrophobic character. The canonical GST structure has a binding
site known as the H-site, which accommodates a hydrophobic moiety and
is adjacent to the glutathione binding G-site. The H-site is
constructed from elements of both the N- and C-terminal domains, and
variations of these between different GST classes reflect the varying
substrate specificities of GSTs.
GSTO 1-1 possesses a well defined cavity adjacent to the GSH binding
site in the same relative location as the H-site in other GSTs, and
this is presumed to be the binding site for a substrate or other
molecular target (Fig. 10). One side of
this wide and deep pocket is formed by Phe-31 and Pro-33, which flank
the putative catalytic or otherwise reactive Cys-32. Residues from the
C-terminal helix Our sequence-based searches of the human EST data base identified
what appeared to be a new member of the GST structural family. Independently, a recent study evaluating a new data base searching tool
suggested the existence of an additional GST family in the mouse (41).
The unknown enzyme was termed GSTX. Sequence comparisons indicate that
GSTX is the orthologue of the human GSTO 1-1 characterized in this
study. Because the term GSTX does not conveniently lend itself to the
established nomenclature (31), we have named the new gene family Omega.
Sequence alignment suggested that GST Omega was a new member of the GST
structural family, and phylogenetic analysis confirmed that the Omega
class GSTs form a cluster distinct from the previously described
classes. Further detailed phylogenetic studies are required to gain a
greater understanding of the evolutionary history of the GSTs and the
clear demarcation of the different classes. Our analysis of the GSTO
1-1 structure has also confirmed its membership of the GST superfamily.
GSTO 1-1 is a dimer of subunits that adopt a characteristic GST fold
with an N-terminal Several features set GSTO 1-1 apart from the other members of the GST
superfamily. Its N-terminal region has a unique extension of
approximately 19 residues when compared with other cytosolic GSTs. This
contains a proline-rich segment that in conjunction with the C terminus
forms a distinct structural unit with an unknown function. An active
site Cys is another notable feature of GSTO 1. Previously characterized
eukaryotic GSTs have a tyrosine or serine residue within
hydrogen-bonding distance of the sulfur atom of the bound glutathione
(8, 10). It is generally considered that a H-bond between the GSH
sulfur and the OH of the tyrosine or serine stabilizes the thiolate
anion of GSH (42). Mutation of the active site tyrosine and serine
residues found in other GSTs generally results in a substantial, if not
complete, inactivation (8, 9). Consequently the absence of an
equivalent residue in the Omega class GSTs suggests that they may not
catalyze the glutathione conjugation reactions typical of many GSTs.
The Theta class isoenzyme GSTT 2-2 provides an interesting example of a novel reaction that does not require the presence of a H-bond from a
nearby hydroxyl to stabilize the GSH thiolate. GSTT 2-2 acts as a
sulfatase with menaphthyl sulfate and generates menaphthyl glutathione
and free sulfate. Mutagenesis has suggested that this reaction is not
dependent on the presence of a serine and may be a product of the
environment generated by a number of residues (43, 44). This notable
difference demonstrates that some reactions catalyzed by GSTs can take
place in the absence of a tyrosine or serine residue, and an equivalent
mechanism may be utilized by the Omega class GSTs.
Studies of the enzymatic properties of GSTO 1-1 also indicated that it
probably is not a typical GST. Known substrates for other members of
the GST superfamily were not turned over by GSTO 1-1. Interestingly,
GSTZ 1-1, the human GST with the closest sequence similarity to GSTO
1-1, catalyzes glutathione-dependent conversion of
dichloroacetic acid to glyoxylic acid (45), but GSTO 1-1 has no
significant activity against dichloroacetic acid. Thus, the enzymatic
capabilities of GSTO 1-1 appear distinct from those of other GSTs. The
only significant activity observed for GSTO 1-1 was the ability to act
as a glutathione-dependent S-thioltransferase. This type of activity is consistent with expectations that Cys-32 serves as a nucleophilic center, based on structural homology to
thioredoxin and glutaredoxin and preliminary unpublished studies indicating that the enzymatic activities of GSTO 1-1 are sensitive to
alkylation by N-ethylmaleimide. Potential
disulfide-containing molecules that may serve as natural substrates for
this type of activity include S-thiolated polypeptides. For example,
following oxidative stress a number of cellular proteins form S-thiol
adducts with glutathione and cysteine (46, 47), and formation of these adducts can inactivate enzymatic functions of the affected polypeptides (48, 49). A conceivable function for GSTO 1-1 is to reduce this type of
S-thiol adduct and restore enzymatic function. Interestingly, the
crystal structure of GSTO 1-1 indicates that its H site is open to the
surface and large enough to accommodate a polypeptide chain.
Mouse and rat orthologues of GSTO 1-1 have been identified and
characterized in recent reports. Comparison of the cDNAs prepared from radiation-sensitive and radiation-resistant populations of mouse
lymphoma cells identified a 28-kDa polypeptide (p28) as more highly
expressed in the resistant cells (50). The p28 protein (GenBankTM
number accession U80819) is predicted to be expressed as a 240-residue
polypeptide. This is one amino acid shorter than human GSTO 1-1, with
the extra residue in the human sequence (Thr-162) occurring in a
surface loop. p28 has 72% sequence identity with human GSTO 1-1, with
many conservative replacements where the sequences differ.
In apparent contrast to our findings with GSTO 1-1, p28 is reported to
bind to agarose-coupled glutathione. However, our studies were
conducted using Glutathione-Sepharose (Amersham Pharmacia Biotech), in
which glutathione is linked to the support through its sulfydryl. The
earlier study was conducted using Glutathione-agarose (Sigma), in which
glutathione is immobilized through its N terminus and retains the free
thiol. Because Cys-32 of GSTO 1-1 can form a mixed disulfide with
glutathione, murine p28 may have bound to glutathione-agarose
(Sigma) via formation of a covalent adduct. When p28 was released from
the resin by boiling the complex in SDS sample buffer, reducing agent
in the disaggregation buffer may have reduced the mixed disulfide and
liberated the polypeptide. Thus, differences in the composition of the
affinity matrix may explain the apparent differences in glutathione
binding by the mouse and human proteins.
Like GSTO 1-1, p28 lacks demonstrable GST activity, and the recombinant
mouse protein is devoid of glutathione peroxidase activity (50).
Moreover, message encoding GSTO 1-1 and p28 is expressed by many
tissues, with liver and heart containing the highest levels.
Interestingly, p28 is reported to change its subcellular location in
response to heat (50). On this basis p28 may represent a component of
the stress response mechanism of the cells.
A rat orthologue of GSTO 1-1 (GenBankTM number accession AB008807) has
been purified from rat liver on the basis of its ability to catalyze a
glutathione-dependent reduction of dehydroascorbic acid
(32). Like its human and mouse orthologues, the rat protein is widely
expressed, with rat liver and kidney demonstrating the highest levels.
The recombinant rat protein was not shown directly to catalyze the
glutathione-dependent reduction of dehydroascorbic acid. Rather, cells overexpressing the recombinant protein were reported to
accumulate more ascorbic acid than non-transfected control cells
following exposure to dehydroascorbate, and this was interpreted as
evidence of greater dehydroascorbate reductase activity. Human recombinant GSTO 1-1 demonstrated dehydroascorbate reductase activity, but its magnitude was rather low. Pig liver glutaredoxin, for example,
possesses a specific activity of 134 units/mg as a
glutathione-dependent dehydroascorbate reductase (21), but
the specific activity of GSTO 1-1 for this same reaction is 0.16 units/mg (1 unit is equivalent to 1 µmol/min). Therefore, the extent
to which GSTO 1-1 serves as a glutathione-dependent
dehydroascorbate reductase in vivo remains to be determined.
The wide and relatively abundant expression of GSTO 1-1 in most tissues
and the detection of similar sequences in species ranging from C. elegans to humans suggests that it may have a significant
housekeeping role. Protection against oxidative stress is an ancient
and ongoing problem for living organisms. Given the catalytic
proclivities of GSTO 1-1 detected so far and the overexpression of its
mouse orthologue in radiation-resistant cells, it is conceivable that
it plays a significant role in the cellular response to oxidative stress.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
80 °C.
Activity of recombinant GST0 1-1 with various substrates
-actin cDNA probe to
evaluate track loading. Western blots were developed with a 1:400
dilution of rabbit antiserum raised against His-tagged recombinant GSTO
1-1, and goat anti-rabbit IgG alkaline phosphatase conjugate (Sigma)
(22). The primary antiserum does not cross-react with native GSTs from
the other classes; however, we have noted some cross-reactivity with
recombinant proteins expressed with the poly-His tag.
= 0.9795 Å), the inflection point
(minimum f ',
= 0.9802 Å), and a high energy
wavelength remote from the edge (
= 0.9500 Å). Inverse beam
geometry was employed, and data were collected in two 75° sweeps in
0.5° oscillation steps for each wavelength, using a Brandeis
charge-coupled device detector. All data were indexed, measured, and
scaled with the DENZO and SCALEPACK programs (23) and then processed
with the CCP4 package (24). Data on native (i.e. not
SeMet-substituted) crystals with and without glutathione covalently
bound were collected on a Rigaku Raxis II image plate detector using
copper-K
x-rays from a Rigaku RU-200 generator equipped with
Molecular Structure Corp. focusing mirrors. Relevant statistics are
given in Table II.
Structure determination statistics

View larger version (60K):
[in a new window]
Fig. 1.
Stereo view of a part of the experimental
electron density map after solvent flipping, contoured at
2.0
. The region shown is part of the
N-terminal extension, residues Gly12-Pro18
A-weighted 2 Fo
Fc maps (30). The final model contained 110 water molecules, 2 sulfate ions, disulfide-linked GSH, and the entire polypeptide minus the first seven
residues. Final model statistics are shown in Table
III.
Refinement statistics
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (46K):
[in a new window]
Fig. 2.
Nucleotide and deduced amino acid sequences
of GSTO 1. The poly(A) addition signal is
underlined.

View larger version (32K):
[in a new window]
Fig. 3.
An unrooted phylogeny showing the most likely
relationship between representative GST and GST-like amino acid
sequences. Branch lengths are proportional to estimates of
evolutionary change. The number associated with each internal branch is
the local bootstrap probability that is an indicator of confidence.
Another five locally optimal trees were found, none of which differ
significantly from the most likely tree. The differences between the
six trees were confined to the branches, indicated by dashed
lines. The sequences are (species name; GenBankTM accession
number): nematode Omega (C. elegans; L23651), mouse Omega
(Mus musculus; U80819), rat Omega (Rattus rattus;
AB008807), human Omega (Homo sapiens; AF212303), soybean
heat-shock protein (HsPr) (Glycine max; M20363),
potato GST (Solanum tuberosum; J03679), yeast membrane
protein (MbPr, Saccharomyces cerevisiae; Z73165),
nematode Zeta (C. elegans, Z66560), human Zeta (H. sapiens, NM_001513), carnation Zeta (Dianthus
caryophyllus, M64268), Escherichia stringent starvation
protein (StStPr) (E. coli, X05088),
Proteus GST (Proteus mirabilis, U38482),
Escherichia GST (E. coli, D38497),
Ochrobactrum GST (Ochrobactrum anthropi, Y17279),
Arabidopsis Phi (A. thaliana, D17672), Petunia
Phi (Petunia hybrida, Y07721), blowfly Delta (L. cuprina, L23126), house fly Delta (Musca domestica,
X61302), fruit fly Delta (Drosophila melanogaster, X14233),
mouse Theta (M. musculus, U48419), human Theta (H. sapiens, NM_000854), mouse Mu (M. musculus, J03952),
human Mu (H. sapiens, NM_000848), chicken Mu (Gallus
gallus, X58248), rat Pi (Rattus norvegicus, L29427),
human Pi (H. sapiens, NM_000852), rat Sigma (R. norvegicus, D82071), human Sigma (H. sapiens, D82073),
squid2 Sigma (Ommastrephens sloanei, M36938), squid1 Sigma
(O. sloanei, M36937), human Alpha (H. sapiens,
NM_000846), mouse Alpha (M. musculus, M73483), and chicken
Alpha (G. gallus, L15386).
-actin
probe shows strong hybridization to an extra 1.8-kilobase band that
tends to obscure the 2-kilobase
-actin band found in all tissues. A
survey of the EST data base has confirmed that GSTO 1 is expressed in a
wide range of human tissues including aorta, bone, brain, breast,
central nervous system, colon, esophagus, foreskin, germ cell, heart,
kidney, lung, lymph, muscle, ovary, pancreas, parathyroid, placenta,
prostate, spleen, stomach, testis, uterus, and whole embryo. The broad
range of expression of GSTO 1 contrasts with many other GSTs that show distinct tissue-specific expression and suggests that it plays a
fundamental role in cellular metabolism.

View larger version (63K):
[in a new window]
Fig. 4.
Tissue distribution of GSTO 1-1 mRNA
expression. The blotted RNA was initially hybridized with the GSTO
1-1 cDNA, then rehybridized with a
actin cDNA to evaluate
RNA loading.

View larger version (39K):
[in a new window]
Fig. 5.
Structure of human GSTO 1-1. A,
the GSTO 1-1 dimer, as seen looking down the 2-fold axis. The N- and
C-terminal extensions (see text under "Crystal Structure of
GSTO 1-1") are highlighted in red. The GSH molecules
and bound sulfate ions are indicated in ball and stick
representation. B, a ribbon representation of the monomer.
Residues were assigned to secondary structural elements according to
criteria defined by Kabsch and Sander (51). The secondary structure
nomenclature has been made consistent with other published GST
structures. Helices
2 and
10 are 310 helices, and
other helices are
-helices. These images were generated using the
program RIBBONS (52).
-helical. The N-terminal domain consists of a central four-stranded
-sheet flanked on one
side by two
-helices (
1, residues 32-45;
3, residues 85-97) and on the other side by a 310 helix (
2, residues
60-66). The N-terminal extension identified by sequence
alignment2 forms a distinct structural unit that other
structures lack (Fig. 6). Residues 5-22
form an extended structure on the surface of the protein that leads
into the first
-strand (
1, 23-28) (Figs. 5A and
6).

View larger version (62K):
[in a new window]
Fig. 6.
The common chain fold of the GST
superfamily. The coordinates of all nine structures were
superimposed and then pulled apart for clarity. Helices are represented
as cylinders, and
-strands are represented as
arrows. Assignment of secondary structure was done according
to criteria defined by Kabsch and Sander (51). Protein data bank codes
and references for the structures used are: alpha, 1gse (53); beta,
2pmt (36); delta, (40); theta, 1ljr (54); mu,1hna (55); pi, 1glp (56);
sigma, 1gsq (57); phi, 1gnw (39); omega, 1eem (this work). Images in
this figure were drawn using the programs MOLSCRIPT (58) and RASTER3D
(59).
-helices in the C-terminal domain, five (
4,
5,
6,
7,
8) are common to most members of the GST folding
superfamily (Fig. 6), but the last two (
9, 219-230 and
10,
235-239) fold back over the top of the N-terminal domain and set the
present structure apart. This C-terminal extension makes several
H-bonds with the N-terminal domain and forms a continuous surface with the N-terminal extension (Fig. 7)

View larger version (100K):
[in a new window]
Fig. 7.
Surface representation of the GST-Omega
dimer, looking down the 2-fold axis. The N- and C-terminal
extensions (see text under "Crystal Structure of GSTO
1-1") are colored green and purple,
respectively. GSH molecules are shown in ball and stick
representation. This figure was drawn using the program GRASP
(60).
1, with its thiol precisely
over the helix axis. This placement is exactly as seen for the thiol of
the N-terminal cysteine of the Cys-Xaa-Xaa-Cys motif of thioredoxin,
glutaredoxin, and DsbA (Fig. 8 shows
structural overlap of GSTO 1-1 and glutaredoxin). This structural
feature appears likely to have major implications for the function of GSTO 1-1. As shown by Kortemme and Creighton (38), the proximity of the
Cys side chain to the positive end of a helix dipole substantially lowers the thiol pKa and creates the potent
nucleophilicity of the exposed cysteine in thioredoxin and its
relatives. The proline following this cysteine, as Pro-33 follows
Cys-32 of GSTO 1-1, promotes optimal positioning of the Cys-32 thiol
for stabilization of the thiolate form (38).

View larger version (25K):
[in a new window]
Fig. 8.
Comparison of the GSH binding loop in
glutaredoxin (left) and GST-Omega
(right). The glutaredoxin structure shown is from
Protein Data Bank entry 3grx, an NMR structure determination of the
C15S mutant of E. coli glutaredoxin complexed with GSH. The
figure shows residues 1-23 in glutaredoxin and residues 23-44 in
GST-Omega from the superimposed protein structures. Cys-11 from
glutaredoxin and Cys-32 from GST-Omega are shown in ball and
stick representation.
4 of the
second subunit (Asp-101 in GST-Alpha, Glu-104 in GST-Beta, Asp-105 in GST-Mu, Asp-98 in GST-Pi, Asp-101 in GST-Sigma, and Asp-104 in mammalian GST-Theta). The corresponding residue in GSTO 1-1 is Lys-122.
The GSTO 1-1 dimer has an atypically open, V-shaped configuration. Contacts between the subunits are confined to side chains from
4,
3, and
4. Most of the interactions at the interface are non-polar
in character, with no H-bonds and only two salt bridges (the two
instances of Lys-114-Glu-91). The relative orientation of the monomers
at the subunit interface is consistent with the orientation seen in the
other GST crystal structures (10), but the interface is more open than
in any of the other GST dimers. The buried area at the interface is
1960 Å2, compared with 2700-3400 Å2 in most
other GST dimers. The plant Theta-like GSTs (39), which also lack an
inter-subunit interaction involving GSH, have a relatively open dimer
interface with a buried surface area of 2370 Å2.

View larger version (26K):
[in a new window]
Fig. 9.
Schematic illustrating the residues
contacting GSH. This figure was generated using the program
LIGPLOT (61).
8, a distinctive feature of GSTO 1-1, form the top
and back of this pocket. Particularly interesting is Trp-222, with its
indole nitrogen pointing into the pocket. The indole nitrogen contributes one additional H-bond to the pocket, making the pocket that
much less hydrophobic. Another polar atom is contributed by the side
chain of Arg-183, the N
atom of which forms the bottom of the
pocket. The open subunit interface and the relatively polar nature of
the H-site suggest that the substrate or other binding partner for GSTO
1-1 could be a large and not entirely hydrophobic molecule. The cleft
between the subunits is large enough that binding to another protein
appears possible.

View larger version (93K):
[in a new window]
Fig. 10.
Putative substrate or target-binding site in
GSTO 1-1. A GRASP image shows the deep cleft adjoining the
GSH-binding site that corresponds to the H-site in other GST
structures. The surface is colored according to electrostatic potential
(blue, positive; red, negative; white,
neutral). Some of the residues forming the walls of the pocket are
indicated (see text under "The H-site").
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
GSH binding domain and a C-terminal domain
composed entirely of
helices.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Salvatore Sclafani and Robert Sweet for assistance with the data collection and John P. Overington for the program MNYFIT used for calculating all protein structure overlaps. The School of Biological Sciences at the University of Sydney is gratefully acknowledged for providing temporary space and resources to L. S. Jermiin.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF212303.
The atomic coordinates and structure factors (code 1eem) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§ To whom correspondence should be addressed. To P. Board: Tel.: 61 2 62494714; Fax: 61 2 62490413; E-mail: Philip.Board@anu.edu.au. To J. Pandit: Tel.: 860-441-3738; Fax: 860-441-4734; E-mail: pandit@ pfizer.com.
Recipient of an Australian Research Council post-doctoral fellowship.
Published, JBC Papers in Press, April 26, 2000, DOI 10.1074/jbc.M001706200
2 Further details are available from Dr. Philip Board at the John Curtin School of Medical Research web site.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GST, glutathione S-transferase; EST, expressed sequence tag; PAGE, polyacrylamide gel electrophoresis; SeMet, selenomethionine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hayes, J. D., and Pulford, D. J. (1995) Crit. Rev. Biochem. Mol. Biol. 30, 445-600 |
| 2. | Sekine, Y., Hommura, S., and Harada, S. (1995) Exp. Eye Res. 60, 159-163 |
| 3. | Hall, A. G., Autzen, P., Cattan, A. R., Malcolm, A. J., Cole, M., Kernahan, J., and Reid, M. M. (1994) Cancer Res. 54, 5251-5254 |
| 4. | Zimniak, P., Nanduri, B., Pikula, S., Bandorowicz-Pikula, J., Singhal, S. S., Srivastava, S. K., Awasthi, S., and Awasthi, Y. C. (1994) Eur. J. Biochem. 224, 893-899 |
| 5. | Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., and Le Couteur, D. G. (1998) Lancet 352, 1344-1346 |
| 6. | Board, P. G., Baker, R. T., Chelvanayagam, G., and Jermiin, L. S. (1997) Biochem. J. 328, 929-935 |
| 7. | Washburn, M. P., and Wells, W. W. (1999) Biochem. Biophys. Res. Commun. 257, 567-571 |
| 8. | Board, P. G., Coggan, M., Wilce, M. C., and Parker, M. W. (1995) Biochem. J. 311, 247-250 |
| 9. | Stenberg, G., Board, P. G., and Mannervik, B. (1991) FEBS Lett. 293, 153-155 |
| 10. | Wilce, M. C., and Parker, M. W. (1994) Biochim. Biophys Acta 1205, 1-18 |
| 11. | Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402 |
| 12. | Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680 |
| 13. | Smith, S. W., Overbeek, R., Woese, C. R., Gilbert, W., and Gillevet, P. M. (1994) Comput. Appl. Biosci. 10, 671-675 |
| 14. | Jones, D. T., Taylor, W. R., and Thornton, J. M. (1992) Comput. Appl. Biosci. 8, 275-282 |
| 15. | Adachi, J., and Hasegawa, M. (1996) MOLPHY Version 2.3 , The Institute of Mathematical Statistics, Tokyo |
| 16. | Kishino, H., and Hasegawa, M. (1989) J. Mol. Evol. 29, 170-179 |
| 17. | Whittington, A., Vichai, V., Webb, G., Baker, R., Pearson, W., and Board, P. (1999) Biochem. J. 337, 141-151 |
| 18. | Doublie, S. (1997) Methods Enzymol. 276, 523-530 |
| 19. | Tong, Z., Board, P. G., and Anders, M. W. (1998) Chem. Res. Toxicol. 11, 1332-1338 |
| 20. | Axelsson, K., Eriksson, S., and Mannervik, B. (1978) Biochemistry 17, 2978-2984 |
| 21. | Wells, W. W., Xu, D. P., and Washburn, M. P. (1995) Methods Enzymol. 252, 30-38 |
| 22. | Board, P. G. (1998) Biochem. J. 330, 827-831 |
| 23. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 24. | Bailey, S. (1994) Acta Crystallogr. Sec. D 50, 760-763 |
| 25. | Tong, L., and Rossmann, M. G. (1993) J. Appl. Crystallogr. 26, 15-21 |
| 26. | De La Fontelle, E., and Bricogne, G. (1997) Methods Enzymol. 276, 472-494 |
| 27. | Abrahams, J. P., and Leslie, A. G. W. (1996) Acta Crystallogr. Sec. D 52, 30-42 |
| 28. | Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sec. A 47, 110-119 |
| 29. | Brugner, A. T. (1996) X-PLOR, Version 3.1 , Yale University Press, New Haven, Connecticut |
| 30. | Read, R. J. (1986) Acta Crystallogr. Sec. A 42, 140-149 |
| 31. | Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di Ilio, C., Ketterer, B., Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., Pickett, C. B., Sato, K., Widersten, M., and Wolf, C. R. (1992) Biochem. J. 282, 305-306 |
| 32. | Ishikawa, T., Casini, A. F., and Nishikimi, M. (1998) J. Biol. Chem. 273, 28708-28712 |
| 33. | Paolicchi, A., Pezzini, A., Saviozzi, M., Piaggi, S., Andreuccetti, M., Chieli, E., Malvaldi, G., and Casini, A. F. (1996) Arch. Biochem. Biophys. 333, 489-495 |
| 34. | Sinning, I., Kleywegt, G. J., Cowan, S. W., Reinemer, P., Dirr, H. W., Huber, R., Gilliland, G. L., Armstrong, R. N., Ji, X., Board, P. G., Olin, B., Mannervik, B., and Jones, T. A. (1993) J. Mol. Biol. 232, 192-212 |
| 35. | Dal Monte, M., Cecconi, I., Buono, F., Vilardo, P. G., Del Corso, A., and Mura, U. (1998) Biochem. J. 334, 57-62 |
| 36. | Rossjohn, J., Polekhina, G., Feil, S. C., Allocati, N., Masulli, M., De Illio, C., and Parker, M. W. (1998) Structure (Lond.) 6, 721-734 |
| 37. | Patskovsky, Y. V., Patskovska, L. N., and Listowsky, I. (2000) J. Biol. Chem. 275, 3296-3304 |
| 38. | Kortemme, T., and Creighton, T. E. (1995) J. Mol. Biol. 253, 799-812 |
| 39. | Reinemer, P., Prade, L., Hof, P., Neuefeind, T., Huber, R., Zettl, R., Palme, K., Schell, J., Koelln, I., Bartunik, H. D., and Bieseler, B. (1996) J. Mol. Biol. 255, 289-309 |
| 40. | Wilce, M. C., Board, P. G., Feil, S. C., and Parker, M. W. (1995) EMBO J. 14, 2133-2143 |
| 41. | Retief, J. D., Lynch, K. R., and Pearson, W. R. (1999) Genome Res. 9, 373-382 |
| 42. | Armstrong, R. N. (1997) Chem. Res. Toxicol. 10, 2-18 |
| 43. | Flanagan, J. U., Rossjohn, J., Parker, M. W., Board, P. G., and Chelvanayagam, G. (1999) Protein Sci. 8, 2205-2212 |
| 44. | Tan, K. L., Chelvanayagam, G., Parker, M. W., and Board, P. G. (1996) Biochem. J. 319, 315-321 |
| 45. | Tong, Z., Board, P. G., and Anders, M. W. (1998) Biochem. J. 331, 371-374 |
| 46. | Seres, T., Ravichandran, V., Moriguchi, T., Rokutan, K., Thomas, J. A., and Johnston, R. B., Jr. (1996) J. Immunol. 156, 1973-1980 |
| 47. | Hanson, S. R., Chen, A. A., Smith, J. B., and Lou, M. F. (1999) J. Biol. Chem. 274, 4735-4742 |
| 48. | Ravichandran, V., Seres, T., Moriguchi, T., Thomas, J. A., and Johnston, R. B., Jr. (1994) J. Biol. Chem. 269, 25010-25015 |
| 49. | Jahngen-Hodge, J., Obin, M. S., Gong, X., Shang, F., Nowell, T. R., Jr., Gong, J., Abasi, H., Blumberg, J., and Taylor, A. (1997) J. Biol. Chem. 272, 28218-28226 |
| 50. | Kodym, R., Calkins, P., and Story, M. (1999) J. Biol. Chem. 274, 5131-5137 |
| 51. | Kabsch, W., and Sander, C. (1983) Biopolymers 22, 2577-2637 |
| 52. | Carson, M. (1997) Methods Enzymol. 277, 493-505 |
| 53. | Cameron, A. D., Sinning, I., L'Hermite, G., Olin, B., Board, P. G., Mannervik, B., and Jones, T. A. (1995) Structure (Lond.) 3, 717-727 |
| 54. | Rossjohn, J., McKinstry, W. J., Oakley, A. J., Verger, D., Flanagan, J., Chelvanayagam, G., Tan, K. L., Board, P. G., and Parker, M. W. (1998) Structure (Lond.) 6, 309-322 |
| 55. | Raghunathan, S., Chandross, R. J., Kretsinger, R. H., Allison, T. J., Penington, C. J., and Rule, G. S. (1994) J. Mol. Biol. 238, 815-832 |
| 56. | Garcia-Saez, I., Parraga, A., Phillips, M. F., Mantle, T. J., and Coll, M. (1994) J. Mol. Biol. 237, 298-314 |
| 57. | Ji, X., von Rosenvinge, E. C., Johnson, W. W., Tomarev, S. I., Piatigorsky, J., Armstrong, R. N., and Gilliland, G. L. (1995) Biochem. 34, 5317-5328 |
| 58. | Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 945-949 |
| 59. | Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524 |
| 60. | Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins: Structure, Function, Genetics 11, 281-296 |
| 61. | Wallace, A. C., Laskowski, R. A., and Thornton, J. M. (1995) Protein Eng. 8, 127-134 |